1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals

Place of Origin CHINA
Brand Name XRD
Certification GMP
Model Number 1890208-58-8
Minimum Order Quantity negotiable
Price Inquiry for Negotiable
Packaging Details 1-2 Kg / Aluminum Foil Bag, 25kg/ Drum, as Require
Delivery Time 1-2days after payment received
Payment Terms T/T, Western Union,Bitcoin
Supply Ability 5000kg/year

Contact me for free samples and coupons.

Whatsapp:0086 18588475571

Wechat: 0086 18588475571

Skype: sales10@aixton.com

If you have any concern, we provide 24-hour online help.

x
Product Details
Purity 99% Cas No. 1890208-58-8
Product NamRopivacainee Compound 7P Appearance White Powder
Assay 99% Compound 7P Grade Pharmaceutical Grade
Storage Cool Dried Storage Application Pharmaceutical Raw Intermediates
High Light

raw materials for pharma industry

,

intermediates in pharmaceuticals

Leave a Message
Product Description

CAS 1890208-58-8 Pharmaceutical Intermediate Nootropics powder 99% Compound 7P

 

 

 

Description:

 

Chemical Name: 2-[(2-methoxyphenyl)[(4-methylphenyl)sulfonyl]amino]-N-(4-methoxy-3-pyridinyl)acetamide ;2-(N-(2-methoxyphenyl)-4-methylphenylsulfonamido)-N-(4-methoxypyridin-3-yl)acetamide

CAS No.: 1890208-58-8

Reaxys Registry Number: 29568294
Molecular Formula: C22H23N3O5S
Molecular Weight: 441.508

Assay:99%min
InChI Key: NAXWKPFXCOBXLE-UHFFFAOYSA-N

Density(Predicted): 1.329±0.06 g/cm3 |Condition:Temp:20 Press:760Torr

 

Function:

 

Axon regeneration after injury in the central nervous system is hampered in part because if an age-dependent decline in the intrinsic axon growth potential , and one of the strategies to stimulate axon growth in injured neurons involves pharmacological manipulation of implicated signaling pathways.here we report phenotypic cell-based screen of chemical libraries and structure-activity-guided optimization that resulted in the identification of compound 7p which promotes neurite outgrowth of cultured primary neurons derived from the hippocampus, cerebral cortex, and retina. in an animal model of optic nerve injury, compound 7p was shown to induce growth of gap-43 positive axons, indicating that the in vitro neurite outgrowth activity of compound 7p translates into stimulation of axon regeneration in vivo.further optimization of compound 7p and elucidation of the mechanisms by which it elicits axon regeneration in vivo will provide a rational basis for future efforts to enhance treatment strategies.

 

 

 

 

1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals 0

 

 

 

Packing:

 

1890208-58-8 Nootropics Powder 99% Compound 7P Intermediates In Pharmaceuticals 1

 

 

 

 

CAS 1890208-58-8 Pharmaceutical Intermediate Nootropics powder 99% Compound 7P